Definium Therapeutics (DFTX) had the highest return between August 1, 2019 and September 30, 2019 by a mid-cap US stock, returning 410%.
| ASSET | DATE | % RETURN |
|---|---|---|
Definium Therapeutics (DFTX) | 8/1/2019 - 9/30/2019 | 410% |
New Fortress Energy LLC (NFE) | 8/1/2019 - 9/30/2019 | 51.01% |
DRDGOLD Limited ADR (DRD) | 8/1/2019 - 9/30/2019 | 48.12% |
Leonardo DRS, Inc Common Stock (DRS) | 8/1/2019 - 9/30/2019 | 40% |
Palomar (PLMR) | 8/1/2019 - 9/30/2019 | 38.71% |
ACADIA Pharmaceuticals (ACAD) | 8/1/2019 - 9/30/2019 | 37.95% |
Newell Brands (NWL) | 8/1/2019 - 9/30/2019 | 34.67% |
Mesoblast (MESO) | 8/1/2019 - 9/30/2019 | 34.56% |
Insulet (PODD) | 8/1/2019 - 9/30/2019 | 34.5% |
Silvercorp Metals (SVM) | 8/1/2019 - 9/30/2019 | 31.41% |
Ideaya Biosciences (IDYA) | 8/1/2019 - 9/30/2019 | 31.31% |
Shake Shack (SHAK) | 8/1/2019 - 9/30/2019 | 30.48% |
Floor & Decor (FND) | 8/1/2019 - 9/30/2019 | 29.82% |
Aehr Test Systems (AEHR) | 8/1/2019 - 9/30/2019 | 29.71% |
KB Home (KBH) | 8/1/2019 - 9/30/2019 | 29.03% |
Griffon (GFF) | 8/1/2019 - 9/30/2019 | 28.94% |
Skeena Resources (SKE) | 8/1/2019 - 9/30/2019 | 28.74% |
PennyMac Finl Svcs (PFSI) | 8/1/2019 - 9/30/2019 | 27.11% |
Cimpress (CMPR) | 8/1/2019 - 9/30/2019 | 25.8% |
SolarEdge Technologies (SEDG) | 8/1/2019 - 9/30/2019 | 25.72% |
Ambarella (AMBA) | 8/1/2019 - 9/30/2019 | 25.57% |
Synaptics (SYNA) | 8/1/2019 - 9/30/2019 | 24.8% |
ADMA Biologics (ADMA) | 8/1/2019 - 9/30/2019 | 23.27% |
Visteon (VC) | 8/1/2019 - 9/30/2019 | 22.65% |
Northern Oil & Gas (NOG) | 8/1/2019 - 9/30/2019 | 22.5% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.